• No notifications yet.
  • Sign Out
logo image
  • logo image
Registered User? Login

The community gives you the chance to connect and engage with delegates attending this event.

Access to the community is available for registered attendees only. 

If you have already registered, please join using the link below. To register for the event please follow the 'Register for free' button and summit your details. Please contact ftlive@ft.com with any questions.

Forgot Password?
Sign Up
loader image
New User? Sign Up

The community gives you the chance to connect and engage with delegates attending this event.

Access to the community is available for registered attendees only. 

If you have already registered, please join using the link below. To register for the event please follow the 'Register for free' button and summit your details. Please contact ftlive@ft.com with any questions.

Forgot Password?
Login
loader image
      The Next Stage of Pharma's Digital Revolution logo

    The Next Stage of Pharma's Digital Revolution

    Harnessing a new wave of technological transformation
    Watch on-demand now | #FTDigitalDialogues
    watch on-demand

    Presented by
    Partner logo
    In Partnership with
    Partner logo

    Senior Industry Leaders Shared Their Insights

    This timely webinar presented by the Financial Times in partnership with Infosys, brought together life science leaders and technology experts to examine how pharma companies are embracing digital to deliver real and impactful change in their organisations while overcoming barriers to change. It explored the evolution of digital in pharma, what’s next on the horizon and how the on-going digital transformation will impact and reshape the operational and business models of the industry.

    SEE FULL OVERVIEW

    Key Takeaways

    Digital Integration

    The industry has progressed some way on its digital journey over the last few years, with digital moving from the back office to become a fully integrated part of business. Pharma companies are a ‘dedicated and committed’ to their transformation, with an overwhelming recognition that data and technology will make a difference.

    Adaptation

    Adopting digital at scale requires changing ways of working, building new capabilities, altering processes and changing mindsets. Too often, digital projects get stuck at pilot stage, and many pharma companies lack capability to innovate independently, and are dependent on high-cost external partners. Being able to measure impact of digital programmes will be needed to unlock budget for digital initiatives.

    Human Software

    The real transformation in pharma is ‘human software’ rather than computer software. Improving data literacy across is vital to digital success. The ecosystem around pharma is changing, and consideration is needed of what that means for our business and talent.

    Health Equity

    Issues exist around health equity. Many digital apps today are built by healthy people for healthy people, rather than for those who may suffer most, or have greatest need.

    Artificial Intelligence

    Artificial intelligence (AI) brings sizeable advantages to pharma, but many primary algorithms still in use today have been in use for decades without significant advances. Quantum leaps in computing power will be needed to resolve some of the biggest scientific challenges, for instance, protein folding. Big tech may have advantages here, and pharma companies will need to decide whether to compete or collaborate, and IP issues will need to be resolved.

    Business Structure

    How pharma organises and structures the business for digital is also a current issue, and it remains to be seen whether centralised, top-down models, or more federated structures and business models will predominate.

    see the agenda

    World-Class Business Leaders and Speakers

    speaker image
    CA
    Catherine Abi-Habib
    Executive Vice President, Strategy, Transformation and Digital
    Ipsen
    speaker image
    SM
    Subhro Mallik
    SVP & Global Head – Life Sciences
    Infosys
    speaker image
    SR
    Shobie Ramakrishnan
    Chief Digital and Technology Officer
    GSK
    speaker image
    S
    Bijoy Sagar
    Chief Information and Digital Transformation Officer
    Bayer AG
    speaker image
    DW
    Diane Wuest
    Global Head of Digital R&D
    Sanofi
    speaker image
    HK
    Hannah Kuchler
    Global Pharmaceuticals Correspondent
    Financial Times

    Why Attend?

    Understand

    The big picture, not just the individual strands of the business you work in

    Connect

    And build relationships with some of the biggest names in your industry

    watch on-demand

    Discover

    New approaches and strategies to help win market share

    FT Live Digital Dialogues - fully digital one hour event experiences delivering maximum engagement. Live webinars provide unique opportunities to engage global senior audiences. All access, digital passes include access to all the live sessions PLUS all sessions on demand for 30 days. Join the conversation.

    watch on-demand

    "An incredibly well-curated event. A great combination of thought-provoking discussions and networking."
    Chanelle Duley University of Auckland

    © Financial Times Live

    FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice

                    

    LEGAL

    FT Live Website Terms of Use
    Slavery Statement & Policies
    Contact us



    FT Live Delegate Terms & Conditions
    Privacy policy
    Cookie policy

Contact the organizer
Contact the organizer